| Quantification of recurrence risk based on number of adverse prognostic factors in women with stage I uterine endometrioid carcinoma | Andrew E. COOK, Ibrahim AREF, Charlotte BURMEISTER, Miriana HIJAZ, Mohamed A. ELSHAIKH | 262–267 |
| Susceptibility to preeclampsia is associated with a 50-bp insertion/deletion polymorphism at the promoter region of the SOD1 gene | Somayeh NAMDARI, Mostafa SAADAT | 268–272 |
| Differential expression of Hsa-miR-517a/b in placental tissue may contribute to the pathogenesis of preeclampsia | Mona Amin-BEIDOKHTI, Hossein SADEGHI, Reihaneh PIRJANI, Latif GACHKAR, Milad GHOLAMI, Reza MIRFAKHRAIE | 273–278 |
| Early-cleavage versus blastocyst stage embryo transfer: a prospective comparative study | Zeynep Öztürk İNAL, Hasan Ali İNAL | 279–285 |
| Fetal left ventricular modified myocardial performance index and renal artery pulsatility index in pregnancies with isolated oligohydramnios before 37 weeks of gestation | Ayşegül ÖZEL, Hakan ERENEL, Rıza MADAZLI, Funda ÖZTUNÇ | 286–292 |
| The efficacy of dydrogesterone use to suppress premature luteinizing hormone surge on cycle outcomes in controlled ovarian stimulation | Gülşen Doğan DURDAĞ, Yavuz Emre ŞÜKÜR, Cem ATABEKOĞLU, Bülent BERKER, Ruşen AYTAÇ, Murat SÖNMEZER, Batuhan ÖZMEN, Gizem BEKTAŞ, Esengül TÜRKYILMAZ, Halime GÖKTEPE, Meltem SÖNMEZER | 293–299 |
| Reference ranges for flow velocities and the indices of the ductus venosus in low-risk pregnancies | Cemil GÜRSES, Burak KARADAĞ, Ceyda KARADAĞ, Onur EROL | 300–311 |
| Comparison of perioperative outcomes among robotassisted, conventional laparoscopic, and abdominal/ open myomectomies | Mete GÜNGÖR, Esra ÖZBAŞLI | 312–318 |
| Perioperative considerations in the treatment of endometriosis | Nicolai MAASS, Ibrahim ALKATOUT, Liselotte METTLER, Damaris FREYTAG, Göntje PETERS, Georgios GITAS | 319–325 |
| An overview of polycystic ovary syndrome in aging women | Mehmet Faruk KÖSE, Özlem ÇELİK | 326–333 |
| False-positive results of lupus anticoagulant tests should be kept in mind in pregnant patients receiving low molecular weight heparin |